Dow Down 0.22% Nasdaq Up 0.14%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTH.TO)

-Toronto
7.70 Up 0.10(1.32%) Aug 22, 2:27PM EDT
Prev Close:7.60
Open:7.48
Bid:5.44
Ask:7.70
1y Target Est:N/A
Beta:0.66
Earnings Date:Sep 8 - Sep 12 (Est.)
Day's Range:7.27 - 7.70
52wk Range:4.04 - 9.25
Volume:1,693
Avg Vol (3m):2,230
Market Cap:234.36M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

» More Headlines for TTH.TO

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.50
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-14) :-0.64
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, develops therapeutics for various disease indications primarily in Canada. Its lead CNS drug candidate includes ELND005, a Phase II clinical trial product for the treatment of Alzheimer... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback